Document Detail

Inflammatory factor increases cyclooxygenase expression on the development of no-reflow.
MedLine Citation:
PMID:  25399887     Owner:  NLM     Status:  Publisher    
No-reflow after reperfusion therapy for myocardial infarction is a strong predictor of clinical outcome. Increased level of inflammatory factors including C-reactive protein (CRP) levels in patients with acute myocardial infarction (AMI) undergoing primary percutaneous coronary intervention (PCI) may affect myocardial perfusion. However mechanisms that no-reflow increases in inflammation stress on the no-reflow phenomenon of AMI are not clear. The purpose of current study was to determine the effects and molecular mechanisms of CRP on the expression of cyclooxygenase (COX) on the development of no-reflow. We first demonstrated inflammatory factors CRP and interleukin-6 (IL-6) were significantly increased in no-reflow patients, suggesting that inflammatory factors play an important role on the development of no-reflow. The next we research the mechanisms by generating the animal model mimicking the no-reflow phenomenon. Compared with the normal reflow rats, COX1 and COX2 were both increased in no-reflow rats. And COX inhibitor indomethacin significantly reduced the no-reflow area. In addition, human coronary artery endothelial cells (HCAEC) were treated with CRP at clinically relevant concentrations for different durations. CRP significantly increased COX1 and COX2 protein levels in a time and concentration-dependent manner. The extracellular signal-regulated kinase (ERK) and Jun N-terminal kinase (JNK) of CRP-treated HCAEC cultures were also activated. Furthermore, ERk inhibitor and JNK inhibitor blocked CRP-induced COX1 and COX2 expression. Together, our data suggested that inflammatory factors CRP can promote the no-reflow development by increasing COX1 and COX2 expression which is partially regulated by ERK and JNK activity. This article is protected by copyright. All rights reserved.
Qibin Jiao; Qiang Ke; Weiwei Li; Meihua Jin; Yan Luo; Linan Zhang; Dong Yang; Xingwei Zhang
Related Documents :
25342737 - Stem cell factor gene transfer improves cardiac function after myocardial infarction in...
24300167 - Q wave area for stratification of global left ventricular infarct size: comparison to c...
25052077 - Post-mortem cardiac diffusion tensor imaging: detection of myocardial infarction and re...
8848207 - Oral sumatriptan-associated transmural myocardial infarction.
7992187 - Right atrial to left atrial shunt through foramen ovale during pneumoperitoneum for lap...
6229497 - Premature closure of the foramen ovale and hypoplasia of the left heart.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-11-15
Journal Detail:
Title:  Clinical and experimental pharmacology & physiology     Volume:  -     ISSN:  1440-1681     ISO Abbreviation:  Clin. Exp. Pharmacol. Physiol.     Publication Date:  2014 Nov 
Date Detail:
Created Date:  2014-11-17     Completed Date:  -     Revised Date:  2014-11-18    
Medline Journal Info:
Nlm Unique ID:  0425076     Medline TA:  Clin Exp Pharmacol Physiol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
This article is protected by copyright. All rights reserved.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Clinical characteristics of Japanese oropharyngeal squamous cell carcinoma positive for human papill...
Next Document:  [Risk factors of the occurence and death of acute respiratory distress syndrome: a prospective multi...